At Mount Sinai Medical School in New York City, many of the medical students majored in things like English or history, and they never took the MCAT. The institution sees that diversity as one of its biggest strengths.
The sky-rocketing costs for new drugs are propelling the effort. But pharmaceutical companies suggest there are better ways to set new pricing models. Also in the news, two patients are suing Anthem Blue Cross, alleging that the insurer would not pay for an expensive new Hepatitis C drug, and a rebuff by the Supreme Court is raising interest among drug maker […]